8-K: BIO-key Reports 2025 Results, Strong Q1 2026 Outlook

BIO-key International, Inc. announced its 2025 financial results, reporting a revenue decline but a substantially improved cash position and strong preliminary Q1 2026 revenue growth, supporting expected growth in 2026.

Summary

• Total revenues for 2025 decreased 12% to $6.1M from $6.9M in 2024.
• Preliminary Q1 2026 revenue is expected to be $2.2M, representing a 37% increase over Q1 2025 and an 80% increase over Q4 2025.
• The net loss for 2025 increased to $4.6M, or ($0.69) per share, compared to a net loss of $4.3M, or ($2.09) per share, in 2024.
• Cash and cash equivalents at December 31, 2025, improved significantly to $2.7M, up $2.3M from $0.4M at year-end 2024.
• Book value increased to $7.6M at year-end 2025 from $3.8M at year-end 2024.
• Operating expenses were reduced by 7% in 2025, including an 11% ($768,000) reduction in SG&A costs.
• The company completed a strategic transition in the EMEA region to selling only BIO-key branded solutions, exiting a previous distribution agreement.
• BIO-key is experiencing strong traction with foreign government, defense, and financial customers, securing significant orders and renewals.
• New partnerships were formed in India, Vietnam, the Middle East, the Nordic region, and with TD Synnex Public Sector (DLT) in the U.S. to expand market reach.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive report. While 2025 financial results showed a decline in revenue and increased net loss, the significant improvement in cash position, substantial reduction in operating expenses, and strong preliminary Q1 2026 revenue growth provide a positive outlook for future performance and a clear path towards profitability.

Positives

• Preliminary Q1 2026 revenue is expected to reach $2.2M, marking a 37% increase over Q1 2025 and an 80% increase over Q4 2025.
• Cash and cash equivalents substantially improved to $2.7M at year-end 2025, an increase of $2.3M from $0.4M at year-end 2024.
• Book value increased to $7.6M at year-end 2025 from $3.8M at year-end 2024.
• Operating expenses were reduced by $669,116, or 7%, in 2025, with SG&A costs decreasing by $767,929, or 11%.
• Hardware revenue increased over 100% to $1.3M in 2025.
• Services revenues increased 6% to $1.2M in 2025 due to a growing customer base.
• Secured a $1M annual license renewal with a long-standing foreign retail bank for expanded use by over 30M clients.
• Foreign military/defense revenue surpassed $2.2M over the latest twelve months, including a $280,000 follow-on order and additional $220,000 orders in Q1 2026.
• Expanded international reach through new partnerships in India (Citadel Global), Vietnam (SAVIS Group), the Middle East and Africa (VaporVM), and the Nordic region (IT2Trust).
• Formed a significant partnership with TD Synnex Public Sector (DLT) to deliver security solutions to U.S. government agencies.
• Gross margin on license fees improved to 91.3% in 2025 from 88.6% in 2024.

Negatives

• Total revenues for 2025 decreased 12% to $6.1M from $6.9M in 2024.
• License fee revenue decreased by $1.6M, or 31%, in 2025, primarily due to a significant contract renewal in 2024 and the exit from the Swivel Secure Limited distribution agreement.
• Net loss increased to $4.6M in 2025 from $4.3M in 2024.
• Gross profit declined to $4.7M with a gross margin of 77.5% in 2025, compared to $5.6M with a gross margin of 81.4% in 2024.
• The audit of the 2025 financial statements has not been completed by the independent registered public accounting firm, and results are therefore subject to change.

Risks

• History of losses and limited revenue.
• Ability to raise additional capital to satisfy working capital needs.
• Ability to continue as a going concern.
• Ability to protect intellectual property.
• Changes in business conditions, sales strategy, and product development plans.
• Changes in the marketplace.
• Continued services of the executive management team.
• Security breaches.
• Competition in the biometric technology and identity access management industries.
• Market acceptance of biometric products generally and products under development.
• Ability to convert sales opportunities to customer contracts.
• Ability to expand into Asia, Africa, and other foreign markets.
• Fluctuations in foreign currency exchange rates.
• The duration and extent of continued hostilities in Ukraine and its impact on European customers.
• The impact of tariffs and other trade barriers which may make it more costly to import inventory from China and Hong Kong and certain product components from South Korea.
• Delays in the development of products.
• Temporary loss of the use of a Registration Statement on Form S-3 to register securities in the future.
• Any disruption to the business that may occur on a longer-term basis if unable to continue to maintain effective internal controls over financial reporting.

Future Outlook

BIO-key expects solid revenue growth and an improved bottom line in 2026, aiming to achieve break-even results in early 2026. The company anticipates increased software license fees and overall revenues due to expanding customer deployments and a broadening pipeline of opportunities. Financial performance will likely fluctuate on a quarterly basis due to the timing of large orders, but the company expresses excitement about its outlook for 2026 and beyond.

Management Comments

• "We had a broad base of achievements in 2025, the revenue and bottom-line benefits of which will be realized in early 2026 and beyond."
• "Despite the impact to license revenue in 2025, the transition provides significant benefits to our gross margin and growth prospects as we work to rebuild a broader pipeline of EMEA partner and other opportunities."
• "Based on expanding customer deployments and a broadening pipeline of opportunities, we expect growth in software license fees and overall revenues in 2026."
• "We are off to a strong start with preliminary Q126 revenue expected to grow 37% over Q125 to approximately $2.2M and driving a substantial improvement in our bottom-line versus prior periods. It's a good start toward our goal of achieving break-even results in early 2026."
• "Given the strength of our solutions for these mission critical applications, we are confident in our growth prospects for the defense industry in 2026."
• "Today, with our current cash position and expected cash receipts, we have solid working capital to deliver on our growth plan in 2026."
• "We expect top-line expansion combined with expense management to advance our goal of reaching break-even in 2026."

Industry Context

StockSavvy.ai notes that BIO-key's focus on biometric-centric Identity and Access Management (IAM) solutions aligns with the growing global demand for enhanced cybersecurity, particularly in critical sectors like government, defense, and finance. The company's expansion into new international markets and partnerships with large technology providers like TD Synnex Public Sector positions it to capitalize on increasing regulatory mandates for 'Zero Trust' infrastructure and phish-resistant Multi-Factor Authentication (MFA), reflecting broader industry trends towards more robust and convenient authentication methods.

Comparison to Industry Standards

• The company's expansion into India via Citadel Global and positioning for opportunities created by the EU-India Free Trade Agreement with a free-trade zone for 2 billion people indicates a strategic move into a large, growing market, comparable to other global identity solution providers seeking to leverage emerging market opportunities.
• Delivering identity security across Mozambique's national payments infrastructure led by SIMO, making it the 11th financial services customer globally, demonstrates significant traction in the financial sector, a critical infrastructure area where competitors like Okta, Ping Identity, and Microsoft also offer identity solutions.
• The partnership with TD Synnex Public Sector (DLT), a large technology solutions provider with over $60B in annual sales, provides public sector access and a streamlined procurement path for U.S. government agencies, a competitive landscape where companies like SailPoint and CyberArk also compete for government IAM contracts.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value due to improved cash position, cost management, and expected revenue growth in 2026, though 2025 results were negative. The increase in weighted average common shares outstanding from 2,059,884 in 2024 to 6,647,702 in 2025 indicates significant dilution, likely from warrant exercises and other equity issuances.
• Customers: Benefit from expanded product offerings (BIO-key branded solutions in EMEA), new product introductions (ECOID III Fingerprint Scanner, Passwordless Innovations), and broader geographic reach through new partnerships, enhancing access to secure IAM solutions.
• Employees: Reorganization of sales personnel costs mentioned, which could imply changes in roles or staffing, but overall cost reduction efforts aim to improve company stability.
• Creditors: Improved cash position and book value strengthen the company's financial health, potentially reducing credit risk.

Next Steps

• Achieve break-even results in early 2026.
• Expand customer deployments worldwide, leading to increased service fees.
• Rebuild a broader pipeline of EMEA partner and other opportunities following the strategic transition.
• Continue leveraging the Defense & Intelligence Cybersecurity Initiative.
• Engage with defense prime contractors and end customers.

Key Dates

Recommendation

While BIO-key's 2025 financial performance showed a decline in revenue and an increased net loss, the substantial improvement in cash position, aggressive cost management, and particularly the strong preliminary Q1 2026 revenue growth and positive outlook for achieving break-even in early 2026 suggest a potential turnaround. The strategic shift in EMEA and new partnerships in key sectors and regions are positive long-term indicators. However, the company still faces a history of losses and the 2025 results were negative. A 'hold' recommendation is appropriate as investors should monitor the execution of the 2026 growth plan and the realization of break-even targets before considering a stronger position.

Keywords

BIO-key, BKYI, Identity and Access Management, IAM, biometric authentication, cybersecurity, financial results, Q4 2025, 2025 earnings, Q1 2026 outlook, cash position, revenue growth, defense sector, financial sector, government contracts, international expansion, passwordless, MFA, Zero Trust